CHRS  valuation analysis

Basics
Name: Coherus BioSciences, Inc
Description: Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 06, 2021
Market cap: $960.10M (1258th)
Sales(TTM): $442.68M (1236th)
Earnings(TTM): -$76.28M (1245th)

Value
FFER: 0.52*
Actual price: $13.13
* Earnings were reported Aug 04, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Coherus BioSciences, Inc's earnings decreased from $145.41M to -$76.28M in the last year.
  • Coherus BioSciences, Inc's operating income decreased from $165.24M to -$51.91M in the last year.
Earnings / MarketCap
Coherus BioSciences, Inc
"Biotechnology" industry
Sales / MarketCap
Coherus BioSciences, Inc
"Biotechnology" industry
Book / MarketCap
Coherus BioSciences, Inc
"Biotechnology" industry
Equity / Assets
Coherus BioSciences, Inc
"Biotechnology" industry